AI Verdict
MAYS has stronger fundamentals based on our AI analysis.
MAZE vs MAYS Fundamental Comparison
| Metric | MAZE | MAYS |
|---|---|---|
| Revenue | $0.0 | $10.5M |
| Net Income | $-131.1M | $-842,987.0 |
| Net Margin | N/A | -8.1% |
| ROE | -36.9% | -1.6% |
| ROA | -33.0% | -1.0% |
| Current Ratio | 15.50x | 1.65x |
| Debt/Equity | 0.00x | 0.06x |
| EPS | $-3.05 | $-0.42 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MAZE vs MAYS: Frequently Asked Questions
Is MAZE or MAYS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MAYS has stronger fundamentals. MAZE is rated STRONG SELL (92% confidence) while MAYS is rated SELL (75% confidence). This is not investment advice.
How does MAZE compare to MAYS fundamentally?
Maze Therapeutics, Inc. has ROE of -36.9% vs MAYS J W INC's -1.6%. Net margins are N/A vs -8.1% respectively.
Which stock pays higher dividends, MAZE or MAYS?
MAZE has a dividend yield of N/A or no dividend while MAYS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MAZE or MAYS for long term?
For long-term investing, consider that MAZE has STRONG SELL rating with 92% confidence, while MAYS has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MAZE vs MAYS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MAZE vs MAYS, the AI consensus favors MAYS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.